Market Bizzz

The group is currently engaged in exploratory talks with potential overseas investors, such as global insurance firms, to privately place longer-tenor bonds of up to 30-year maturities, said the people cited above. The bonds will carry fixed coupon rates.

The Swiss bank deal and central banks’ measures to inject liquidity into the markets are restoring market confidence, leading to a relief rally in risk assets, including the crude markets, CMC Markets analyst Tina Teng said.

There have been over 25 large block deals in the past six months in which foreign funds, including Blackstone, Apax Partners, SoftBank, Tiger Global, Bain Capital and General Atlantic, among others, have sold shares worth nearly ₹35,000 crore. Secondary market deals have largely revived from sustained and continued domestic flows.

The largest Swiss bank is exploring an acquisition of all or parts of its smaller rival at the urging of regulators to halt a crisis of confidence, Bloomberg reported earlier.

“The Swiss National Bank’s decision to provide Credit Suisse with significant and inexpensive liquidity fell short of stabilising sentiment in both the equity and credit markets,” Goldman Sachs analyst Lotfi Karoui wrote in a note to clients dated March 17.

So still the trend is weak and sell-on-rise is the strategy. 17300 is the stop-loss for Nifty. For Bank Nifty 40000 is the key level on the higher side if any pullback comes in the coming trading sessions.

“The company wishes to update that it has now ceased negotiations with Bisleri with regard to a potential transaction and to confirm that the company has not entered into any definitive agreement or binding commitment on this matter,” TCPL said in a stock exchange filing on Friday.

Rajesh Gopinathan, the outgoing CEO of TCS, said he would “continue to have a great relationship” with Tata Sons Chairman N Chandrasekaran, irrespective of whether “I am with the group or outside of it”, in an emphatic dismissal of all speculation surrounding his unexpected resignation on Thursday.

Rajesh Gopinathan’s resignation came as a surprise, given that he was just over a year into his second five-year term as MD and CEO.